Taiho Oncology Europe GmbH

Altamira Therapeutics is developing and supplying peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues. Our versatile OligoPhore™ and SemaPhore™ platforms are suited for siRNA, antisense oligonucleotides, mRNA and other RNA modalities and enable strong endosomal release.